Association between androgen-deprivation therapy and non-prostate cancer mortality among men with non-metastatic prostate cancer

Androgen deprivation therapy has been associated with cardiovascular risk factors and the development of cardiovascular disease in men with metastatic prostate cancer. The effect of androgen deprivation therapyon non-prostate cancer mortality is currently unknown among patients with non-metastatic prostate cancer.